Related Experiment Video
Updated: Aug 19, 2026

Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
Vanishing white matter disease in a child presenting with ataxia
C J Wilson1, J C Pronk, M S Van der Knaap
1National Metabolic Service, Starship Hospital, Auckland, New Zealand. callumw@adhb.govt.nz
Insights
Vanishing white matter disease, a neurological disorder, involves episodic deterioration often triggered by fever or trauma. This study reports the first confirmed Australasian patient with this rare leukoencephalopathy.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Vanishing white matter disease (VWMD) is a rare, inherited leukoencephalopathy.
- Characterized by chronic and episodic neurological deterioration, often presenting in childhood with ataxia and tremor.
- Caused by mutations in EIF2B1-5 genes, affecting translation initiation factor eIF2B.
Observation:
- Episodic neurological decline frequently follows fever or minor head trauma.
- Brain MRI reveals extensive cerebral white matter abnormalities, including rarefaction and cystic degeneration.
- Pathological examination confirms white matter abnormalities.
Findings:
- Mutations in any of the five EIF2B genes can cause VWMD.
- The underlying defect in eIF2B leads to dysregulation of protein synthesis.
- This is the first confirmed case of VWMD reported in the Australasian region.
Implications:
- Highlights the genetic basis and biochemical pathways involved in VWMD.
- Emphasizes the importance of early diagnosis and genetic counseling for affected families.
- Contributes to the understanding of leukoencephalopathies and their impact on neurological function.
Abstract:
Vanishing white matter disease is a recently described leukoencephalopathy that is characterized by chronic and episodic neurological deterioration. These episodes often follow periods of fever or minor head trauma. It frequently presents in childhood with problems of ataxia and tremor. Five genes have been identified for the disease, EIF2B1-5, which encode the five subunits of translation initiation factor eIF2B. Mutations in each of the genes may independently cause the disease. The defect in eIF2B results in abnormalities in translation and its regulation, leading to abnormalities in protein synthesis and its regulation. Magnetic resonance imaging of the brain reveals extensive cerebral white matter abnormalities with evidence of white matter rarefaction and cystic degeneration, which has been confirmed pathologically. We report the first confirmed Australasian patient.
Related Concept Videos
Multiple Sclerosis l: Introduction
Huntington Disease l: Introduction
